Erlotinib-d8, CAS [[1266656-97-6]] Preis auf Anfrage

Catalog Number: MCE-HY-50896S3
Article Name: Erlotinib-d8, CAS [[1266656-97-6]] Preis auf Anfrage
Biozol Catalog Number: MCE-HY-50896S3
Supplier Catalog Number: HY-50896S3
Alternative Catalog Number: MCE-HY-50896S3-1UNIT
Manufacturer: MedchemExpress
Category: Biochemikalien
Alternative Names: CP-358774-d8, NSC 718781-d8, OSI-774-d8
Erlotinib-d8 (CP-358774-d8) is deuterium labeled Erlotinib. Erlotinib (CP-358774) is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR. Erlotinib reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM. Erlotinib is used for the treatment of non-small cell lung cancer[1]. Erlotinib is a click chemistry reagent, itcontains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Molecular Weight: 401.49
CAS Number: [1266656-97-6]
Formula: C22H15D8N3O4
Target: Isotope-Labeled Compounds
Application Notes: MCE Product type: Isotope-Labeled Compounds